183 related articles for article (PubMed ID: 8453786)
1. Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain.
Dotta F; Tiberti C; Previti M; Anastasi E; Andreani D; Lenti L; Pontieri GM; Gianani R; Appel MC; Eisenbarth GS
Clin Immunol Immunopathol; 1993 Feb; 66(2):143-9. PubMed ID: 8453786
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside expression in human pancreatic islets.
Dotta F; Colman PG; Lombardi D; Scharp DW; Andreani D; Pontieri GM; Di Mario U; Lenti L; Eisenbarth GS; Nayak RC
Diabetes; 1989 Nov; 38(11):1478-83. PubMed ID: 2695376
[TBL] [Abstract][Full Text] [Related]
4. The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific.
Dotta F; Previti M; Neerman-Arbez M; Dionisi S; Cucinotta D; Lenti L; Di Mario U; Halban PA
Endocrinology; 1998 Jan; 139(1):316-9. PubMed ID: 9421429
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes.
Dotta F; Gianani R; Previti M; Lenti L; Dionisi S; D'Erme M; Eisenbarth GS; Di Mario U
Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721
[TBL] [Abstract][Full Text] [Related]
6. Gangliosides and autoimmune diabetes.
Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
[TBL] [Abstract][Full Text] [Related]
7. Syngeneic islet transplantation in prediabetic BB-DP rats--a synchronized model for studying beta-cell destruction during the development of IDDM.
Christensen UB; Sparre T; Cooke A; Andersen HU; Mandrup-Poulsen T; Nerup J
Autoimmunity; 1998; 28(2):91-107. PubMed ID: 9771979
[TBL] [Abstract][Full Text] [Related]
8. Studies on autoimmunity for initiation of beta-cell destruction. X. Delayed expression of a membrane-bound islet cell-specific 38 kDa autoantigen that precedes insulitis and diabetes in the diabetes-prone BB rat.
Ko IY; Jun HS; Kim GS; Yoon JW
Diabetologia; 1994 May; 37(5):460-5. PubMed ID: 8056182
[TBL] [Abstract][Full Text] [Related]
9. A distinct ganglioside composition of rat pancreatic islets.
Saito M; Sugiyama K
Arch Biochem Biophys; 2000 Apr; 376(2):371-6. PubMed ID: 10775425
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytoplasmic islet cell antigens by rat pancreas.
Dib SA; Colman PG; Dotta F; Tautkus M; Rabizadeh A; Eisenbarth GS
Diabetes; 1987 Aug; 36(8):982-5. PubMed ID: 3109988
[TBL] [Abstract][Full Text] [Related]
11. Inclusion of peripancreatic lymph node cells prevents recurrent autoimmune destruction of islet transplants: evidence of donor chimerism.
Bartlett ST; Chin T; Dirden B; Quereshi A; Hadley G
Surgery; 1995 Aug; 118(2):392-7; discussion 397-8. PubMed ID: 7638756
[TBL] [Abstract][Full Text] [Related]
12. Studies on autoimmunity for initiation of beta-cell destruction. VIII. Pancreatic beta-cell dependent autoantibody to a 38 kilodalton protein precedes the clinical onset of diabetes in BB rats.
Ko IY; Ihm SH; Yoon JW
Diabetologia; 1991 Aug; 34(8):548-54. PubMed ID: 1936657
[TBL] [Abstract][Full Text] [Related]
13. Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.
Cavallo MG; Dotta F; Monetini L; Dionisi S; Previti M; Valente L; Toto A; Di Mario U; Pozzilli P
J Endocrinol; 1996 Jul; 150(1):113-20. PubMed ID: 8708552
[TBL] [Abstract][Full Text] [Related]
14. Prevention of autoimmune islet allograft destruction by engraftment of donor T cells.
Bartlett ST; Schweitzer EJ; Kuo PC; Johnson LB; Delatorre A; Hadley GA
Transplantation; 1997 Jan; 63(2):299-303. PubMed ID: 9020334
[TBL] [Abstract][Full Text] [Related]
15. Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects.
Tiberti C; Dotta F; Anastasi E; Torresi P; Multari G; Vecci E; Andreani D; Di Mario U
Autoimmunity; 1995; 22(1):43-8. PubMed ID: 8882421
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells.
MacKay P; Jacobson J; Rabinovitch A
J Clin Invest; 1986 Mar; 77(3):916-24. PubMed ID: 3512604
[TBL] [Abstract][Full Text] [Related]
17. Target antigens in autoimmune diabetes: pancreatic gangliosides.
Dionisi S; Dotta F; Diaz-Horta O; Carabba B; Viglietta V; Di Mario U
Ann Ist Super Sanita; 1997; 33(3):433-5. PubMed ID: 9542277
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset.
Dotta F; Falorni A; Tiberti C; Dionisi S; Anastasi E; Torresi P; Lernmark A; Di Mario U
J Autoimmun; 1997 Dec; 10(6):585-8. PubMed ID: 9451598
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to fatty acid-induced β-cell dysfunction is enhanced in prediabetic diabetes-prone biobreeding rats: a potential link between β-cell lipotoxicity and islet inflammation.
Tang C; Naassan AE; Chamson-Reig A; Koulajian K; Goh TT; Yoon F; Oprescu AI; Ghanim H; Lewis GF; Dandona P; Donath MY; Ehses JA; Arany E; Giacca A
Endocrinology; 2013 Jan; 154(1):89-101. PubMed ID: 23150493
[TBL] [Abstract][Full Text] [Related]
20. Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM1 antibody.
Jacobson JD; Markmann JF; Brayman KL; Barker CF; Naji A
Diabetes; 1988 Jun; 37(6):838-41. PubMed ID: 3133259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
